Hypromellose Acetate Succinate: Advanced Pharmaceutical Excipient
Unlock enhanced drug delivery with our premium enteric coating and solid dispersion solutions.
Get a Quote & SampleProduct Core Value
Hypromellose Acetate Succinate
Hypromellose Acetate Succinate (HPMCAS) is a sophisticated pharmaceutical excipient designed to revolutionize drug formulation. It serves as a crucial material for enteric coating, providing a protective barrier against gastric acid and ensuring targeted drug release in the small intestine, thereby optimizing medicine absorption. Its unique properties also make it an indispensable carrier for amorphous solid dispersions (ASD), significantly enhancing the solubility and bioavailability of poorly soluble APIs. This makes it a cornerstone for advanced drug delivery systems.
- Leveraging hypromellose acetate succinate enteric coating for pH-dependent drug release, protecting sensitive APIs and ensuring targeted delivery.
- Utilizing HPMCAS as a solid dispersion carrier to overcome solubility challenges for various active pharmaceutical ingredients.
- Enabling aqueous coating polymer for pharmaceuticals, reducing solvent use and promoting greener manufacturing processes.
- Facilitating hot melt extrusion and spray drying applications, crucial for creating stable amorphous solid dispersions.
Key Advantages
Superior Enteric Protection
As an excellent enteric coating polymer, HPMCAS offers robust protection against gastric acidity, ensuring the integrity of sensitive drugs and preventing irritation to the stomach lining. This aligns with the need for precise pH dependent drug release.
Enhanced API Solubility
The application of HPMCAS in improving drug solubility with HPMCAS through solid dispersion techniques is key for developing more effective medications, particularly for APIs with low solubility.
Versatile Processing Options
HPMCAS excels in both aqueous and solvent-based coating processes, offering flexibility for pharmaceutical manufacturers. Its compatibility with techniques like hot melt extrusion further broadens its application scope.
Key Applications
Enteric Coating Systems
Used to formulate pH-sensitive coatings on tablets and granules, providing a barrier against stomach acid for targeted drug release in the small intestine.
Amorphous Solid Dispersions (ASD)
Acts as a critical excipient in ASD formulations, significantly boosting the bioavailability of poorly soluble drugs through techniques like spray drying and HME.
Controlled Release Formulations
Contributes to achieving desired drug release profiles, enabling sustained or delayed release of active pharmaceutical ingredients based on physiological conditions.
Taste Masking
Its film-forming properties can also be utilized for taste masking of bitter APIs, improving patient compliance.